Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia di Hashimoto, M, Saito, Y, Nakagawa, R, Ogahara, I, Takagi, S, Takata, S, Amitani, H, Endo, M, Yuki, H, Ramilowski, JA, Severin, J, Manabe, R-I, Watanabe, T, Ozaki, K, Kaneko, A, Kajita, H, Fujiki, S, Sato, K, Honma, T, Uchida, N, Fukami, T, Okazaki, Y, Ohara, O, Shultz, LD, Yamada, M, Taniguchi, S, Vyas, P, de Hoon, M, Momozawa, Y, Ishikawa, F